Ajax Therapeutics

Ajax Therapeutics is owned by Ajax Health.

View the org chart displaying its 9 main executives

Most searched biographies at Ajax Therapeutics

• Martin Vogelbaum, Interim Chief Executive Officer
• Ramy Farid, Director
• Ross Levine, Director

Popular executive movements at Ajax Therapeutics

• David Steensma has joined the company as Chief Medical Officer  (posted on August 24 2023).

Create your alert
to follow the executive moves at Ajax Therapeutics.

Ajax Health has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Ajax Therapeutics

Social media about Ajax Therapeutics

• Ajax Therapeutics on Wikipedia, Google News & Yahoo Finance
• Ajax Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Martin Vogelbaum

Call Ajax Therapeutics at +1 914...

View the org chart

Register to receive your alert

Report an error